LARGE SCALE
PROCESSING CAPABILITIES

EU-GMP
PHARMA OPERATION

SUPPLY CHAIN
MANAGEMENT

LARGE SCALE PROCESSING CAPABILITIES EU-GMP
PHARMA OPERATION
SUPPLY CHAIN
MANAGEMENT

Processing

Cannabis based solutions

Portocanna is a medical cannabis processor working to create the largest European symbiotic ecosystem of medical cannabis. From our EU-GMP pharmaceutical facility strategically located in Portugal, our large-scale operations support the needs of growers and serve thousands of patients through our distribution partners.

Portocanna specializes in the processing link of the value chain. By investing in complementary capabilities—namely, pharmaceutical operations, biotechnology capabilities, and supply chain management processes—we work with our partners to bring the highest quality pharma-grade products to patients across Europe.

Symbiosis is the most intelligent form of life

The Medical Cannabis industry developed from local markets that faced heavy regulation. This reality created vertically integrated, centralized businesses that focus on a Seed-to Sale strategy. Today, as demand increases and this industry earns growing recognition, we believe that it is now critical to maximize efficiency gains in every link in the value chain.

By creating a large symbiotic network of specialized growers, distributors, and innovators in Europe, we will speed the evolution of the industry and bring patients improved access to the highest quality cannabis-derived products.

Join the hive

imag_ForGrowers

For Growers

Grow your profits.
Reduce your operational risks
imag_ForDistributors

For Distributors

Deliver reliability and product diversity to your patients

imag_ForInnovators

For Innovators

Connect with us. Grow and develop through our network

imag_IconeProduct
PRODUCT

+ Diversity
+ Delivery Methods
+ IP Access

imag_IconeRiskMitigation
RISK MITIGATION

+ Quality Assurance
+ Procurement Network
+ Handling

imag_IconeEconomically
ECONOMICALLY

+ SCALE
RISK

WHO WE ARE

The project was founded by serial entrepreneurs with complementary backgrounds in medical cannabis and biotech, and is supported by a team with more than 85 years of combined experience in EU pharmaceutical operations and extractions of oils.

Our vision has been backed by international Family Offices that have successfully invested in and built billion-euro operations.

WHO WE ARE

The project was founded by serial entrepreneurs with complementary backgrounds in medical cannabis and biotech, and is supported by a team with more than 85 years of combined experience in EU pharmaceutical operations and extractions of oils.

Our vision has been backed by international Family Offices that have successfully invested in and built billion-euro operations.

imag_Assets

ASSETS

Focusing on the processing link of the value chain, we invested in a 3,000sqm EU-GMP certified facility in Portugal comprised of:


Fully equipped post-harvest processing room
Dedicated quality control lab
Certified extraction facility
Large-scale packaging lines
Large warehousing capacity

imag_Capabilities

CAPABILITIES

With the diverse, highly specialized experiences of our team members and the symbiotic partnerships we have developed, we are building:

Efficient operational processes
Vast IP of strains & growers
Strict pharma-grade SOPs
Proprietary extraction methodologies
Unique formulations

Our Partnerships

Complementing our network of local and international growers and distributors, we position ourselves in the the epicentrum of medical Cannabis knowledge and opportunity, creating partnerships with trusted and knowledgeable institutions and companies to share wisdom and design the sustainable future of this industry

Co-financed by: